Literature DB >> 27041094

Improving glucocorticoid replacement in patients with adrenal insufficiency.

Gudmundur Johannsson1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27041094     DOI： 10.1007/s12020-016-0929-2

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  15 in total

1.  Pharmacokinetic evidence for suboptimal treatment of adrenal insufficiency with currently available hydrocortisone tablets.

Authors:  Nicolas Simon; Frederic Castinetti; Floriane Ouliac; Nathalie Lesavre; Thierry Brue; Charles Oliver
Journal:  Clin Pharmacokinet       Date:  2010-07       Impact factor: 6.447

Review 2.  Adrenal insufficiency: review of clinical outcomes with current glucocorticoid replacement therapy.

Authors:  Gudmundur Johannsson; Alberto Falorni; Stanko Skrtic; Hans Lennernäs; Marcus Quinkler; John P Monson; Paul M Stewart
Journal:  Clin Endocrinol (Oxf)       Date:  2014-10-10       Impact factor: 3.478

3.  Epidemiological and clinical picture of Addison's disease.

Authors:  A S Mason; T W Meade; J A Lee; J N Morris
Journal:  Lancet       Date:  1968-10-05       Impact factor: 79.321

4.  Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation.

Authors:  G Johannsson; A G Nilsson; R Bergthorsdottir; P Burman; P Dahlqvist; B Ekman; B E Engström; T Olsson; O Ragnarsson; M Ryberg; J Wahlberg; B M K Biller; J P Monson; P M Stewart; H Lennernäs; S Skrtic
Journal:  J Clin Endocrinol Metab       Date:  2011-11-23       Impact factor: 5.958

5.  Modified-release hydrocortisone decreases BMI and HbA1c in patients with primary and secondary adrenal insufficiency.

Authors:  Marcus Quinkler; Roy Miodini Nilsen; Kathrin Zopf; Manfred Ventz; Marianne Øksnes
Journal:  Eur J Endocrinol       Date:  2015-02-05       Impact factor: 6.664

6.  Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study.

Authors:  Gudmundur Johannsson; Ragnhildur Bergthorsdottir; Anna G Nilsson; Hans Lennernas; Thomas Hedner; Stanko Skrtic
Journal:  Eur J Endocrinol       Date:  2009-04-21       Impact factor: 6.664

7.  Cardiovascular function and glucocorticoid replacement in patients with hypopituitarism.

Authors:  F P Dunne; P Elliot; M D Gammage; T Stallard; T Ryan; M C Sheppard; P M Stewart
Journal:  Clin Endocrinol (Oxf)       Date:  1995-11       Impact factor: 3.478

Review 8.  Replacement therapy of oral hydrocortisone in adrenal insufficiency: the influence of gastrointestinal factors.

Authors:  Hans Lennernäs; Stanko Skrtic; Gudmundur Johannsson
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-06       Impact factor: 4.481

9.  Usefulness of Time-Point Serum Cortisol and ACTH Measurements for the Adjustment of Glucocorticoid Replacement in Adrenal Insufficiency.

Authors:  Elise Rousseau; Michael Joubert; Géraldine Trzepla; Jean Jacques Parienti; Thomas Freret; Marie Christine Vanthygem; Rachel Desailloud; Hervé Lefebvre; Antoine Coquerel; Yves Reznik
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

10.  Prospective evaluation of long-term safety of dual-release hydrocortisone replacement administered once daily in patients with adrenal insufficiency.

Authors:  A G Nilsson; C Marelli; D Fitts; R Bergthorsdottir; P Burman; P Dahlqvist; B Ekman; B Edén Engström; T Olsson; O Ragnarsson; M Ryberg; J Wahlberg; H Lennernäs; S Skrtic; G Johannsson
Journal:  Eur J Endocrinol       Date:  2014-06-18       Impact factor: 6.664
View more
  2 in total

1.  Ramadan fasting in patients with adrenal insufficiency.

Authors:  Mélika Chihaoui; Fatma Chaker; Meriem Yazidi; Wafa Grira; Zohra Ben Amor; Ons Rejeb; Hedia Slimane
Journal:  Endocrine       Date:  2016-11-23       Impact factor: 3.633

2.  Dopamine agonist therapy induces significant recovery of HPA axis function in prolactinomas independent of tumor size: a large single center experience.

Authors:  Christine G Yedinak; Isabelle Cetas; Alp Ozpinar; Shirley McCartney; Aclan Dogan; Maria Fleseriu
Journal:  Endocrine       Date:  2016-07-26       Impact factor: 3.633
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.